| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1881 | |
| Phytochemical name or plant extracts | Perovskia abrotanoides extract | |
| PMID | 27516981 | |
| Literature evidence | The anti-tumor activity of P. abrotanoides root extract has been shown previously. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Hydroalcoholic extract | |
| Source of phytochemicals or plant Extracts | Perovskia abrotanoides | |
| Geographical availability | Afghanistan, Iran, Kazakhstan, Kirgizstan, Mongolia, Pakistan, Tadzhikistan, Tibet, Turkmenistan, West Himalaya | |
| Plant parts | Flowers | |
| Other cancers | Breast cancer, Cervical cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | Hydro-alcoholic extract of P. abrotanoides flowers inhibits the growth of MCF-7 and HeLa cell lines, partly via inducing apoptosis. | |
| Cell line/ mice model | MCF-7 and Hela | |
| Additional information | Antiinflammatory and anti-pain effects of P. abrotenoides is have been mentioned in traditional medicine, as proved in modern animal model researches | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:453762-1 | |
| Safety | NA |